Targeted Cancer Treatment Using Anti-EGFR and -TFR Antibody-Conjugated Gold Nanoparticles Stimulated by Nonthermal Air Plasma

2011 ◽  
Vol 1 (2) ◽  
pp. 179-188
Author(s):  
GonJun Kim ◽  
S. R. Park ◽  
G. C. Kim ◽  
Jae Koo (J. K.) Lee
2011 ◽  
Vol 1 (1) ◽  
pp. 45-54 ◽  
Author(s):  
GonJun Kim ◽  
S. R. Park ◽  
G. C. Kim ◽  
Jae Koo (J.K.) Lee

2014 ◽  
Vol 347 (1) ◽  
pp. 46-53 ◽  
Author(s):  
Jihyoun Lee ◽  
Dev Kumar Chatterjee ◽  
Min Hyuk Lee ◽  
Sunil Krishnan

Author(s):  
Menka Khoobchandani ◽  
Kavita K. Katti ◽  
Alice Raphael Karikachery ◽  
Velaphi C. Thipe ◽  
Pierce L. R. Bloebaum ◽  
...  

Author(s):  
Somayeh Asadi ◽  
Leonardo Bianchi ◽  
Martina De Landro ◽  
Sanzhar Korganbayev ◽  
Emiliano Schena ◽  
...  

ACS Nano ◽  
2014 ◽  
Vol 8 (5) ◽  
pp. 4205-4220 ◽  
Author(s):  
Anil Kumar ◽  
Shuaidong Huo ◽  
Xu Zhang ◽  
Juan Liu ◽  
Aaron Tan ◽  
...  

Author(s):  
Yue Ma ◽  
Lingling Wang ◽  
Haixia Li ◽  
Wen Cheng ◽  
Xiulan Zheng ◽  
...  

Abstract Chemotherapeutic efficacy plays a significant role in the development of nanotheranostic systems for drug delivery in tumor cells. In this study, we demonstrate the self-assembly of C225 conjugate, Perfluorohexane/Gold Nanoparticles (Au-PFH-NPs), which results in low-intensity focused ultrasound diagnosis ablation of thyroid cancer treatment. Cetuximab-Conjugated Perfluorohexane/Gold Nanoparticles (C-Au-PFH-NPs) showed excellent stability in water, PBS, and 20% rat serum. Transmission electron microscopy images revealed the effective construction of C-Au-PFH-NPs with commonly spherical assemblies. The incubation of C625 thyroid carcinoma with C-Au-PFH-NPs triggered apoptosis, which was confirmed by flow cytometry analysis. The C-Au-PFH-NPs showed remarkable antitumor efficacy in human thyroid carcinoma xenografts. The histopathological results additionally confirm the achieved outcomes. Furthermore, we successfully examined the efficiency of C-Au-PFH-NPs when using the thyroid carcinoma low-intensity focused ultrasound (LIFUS) diagnostic imaging in vivo. These findings are clear for LIFUS agents with high performing images. It is also identified that different therapeutic purposes will have extensive potential for future biomedical purposes.


Crystals ◽  
2021 ◽  
Vol 11 (10) ◽  
pp. 1169
Author(s):  
Ștefan Morărașu ◽  
Ștefan Iacob ◽  
Ionuț Tudorancea ◽  
Sorinel Luncă ◽  
Mihail-Gabriel Dimofte

In the field of oncology, a lot of improvements in nanotechnology creates support for better diagnosis and therapeutic opportunities, and due to their physical and chemical properties, gold nanoparticles are highly applicable. We performed a literature review on the studies engaging the usage of gold nanoparticles on murine models with a focus on the type of the carrier, the chemotherapy drug, the target tumoral tissue and outcomes. We identified fifteen studies that fulfilled our search criteria, in which we analyzed the synthesis methods, the most used chemotherapy conjugates of gold nanoparticles in experimental cancer treatment, as well as the improved impact on tumor size and system toxicity. Due to their intrinsic traits, we conclude that chemotherapy conjugates of gold nanoparticles are promising in experimental cancer treatment and may prove to be a safer and improved therapy option than current alternatives.


Sign in / Sign up

Export Citation Format

Share Document